OBN BioTuesday March 16: Who should pay for the commercialization of University Research?  

BioTuesday 16 March: "Who Should Pay for the Commercialization of University Research" 

This event will surely prove to generate a vigorous and thought provoking discussion. The speakers will present three differing perspectives addressing these questions. It will take place at The Innovation Centre, 99 Milton Park, OX14 4RY

Programme:
18.00 Registration with coffee
18.30 Jon Rees, CEO OBN: Welcome and introduction
18.35 Mark Taylor, General Manager, Oxford Biomedical Research Centre
18.50 Linda Naylor, Head of Technology Transfer, Isis Innovation
19.05 William Bains, MD, Rufus Scientific
19:20 Round Table Q&A session with all speakers
19:30 Networking with drinks and Canapés
21.30 Close

About Mark Taylor
Mark Taylor was Operations Manager for the NHS Innovation Hubs while based at NHS Institute of Innovation and Improvement. He is now the General Manager of the Oxford Biomedical Research Centre. Mark sits on the Multiple Sclerosis Society’s Intellectual Property Advisory Group along with the Wellcome Trust and the Medical Research Council.

About Linda Naylor
Before moving to Isis in July 2002, Linda was based at the University of York where she was manager of Bioincubator York Ltd and was responsible for the commercialisation of Bioscience research either through company start-up or licensing. Linda was also part of the White Rose Biotechnology Consortium which was established to exploit the possible synergies between the Universities of York, Sheffield and Leeds to maximise the commercial potential of life science research from the three Universities. Linda has had over 20 years experience in the Life Science industry with Zeneca plc / ICI plc during which time she was responsible for managing the biology research within developing life science businesses covering the pharmaceutical, agrochemical, biopolymer, chemical and food business. Linda has a B.A. in Biological Sciences and an M.B.A. from the Saïd Business School, Oxford.

About William Bains
William is an internationally recognised innovator in the life sciences, with a track record of successfully predicting where new science and technology will lead, and building companies around that understanding that apply new science and make money for investors and entrepreneurs.

After a research career in academia he has worked in technological consulting, venture capital and with start-up biotech companies. In 2000 he founded Amedis Pharmaceuticals, and lead the company through its seed and first round funding, recruitment of a management team, filing its first patents and closing its first pharmaceutical company collaboration. In 2002 he founded Delta G Ltd., a company exploiting the growing field of biogerontology. 

Oxford BRC
The Oxford comprehensive Biomedical Research Centre (OxBRC) is a partnership between the Oxford Radcliffe Hospitals NHS Trust and the University of Oxford. It has been made possible by a £75m grant from the Department of Health's National Institute for Health Research (NIHR) under the programme 'Best Research for Best Health'.

The Oxford BRC undertakes 'translational research', which means taking laboratory research into a clinical setting. This kind of research is about first-time studies of medical innovations in patients, which are intended to improve healthcare delivery for the benefit of all patients.

The organisation is characterised by creative connections and collaborative relationships. These are constructed between different research themes, with other local research resources connected by the partnership engagement group. Broader connections with other NIHR Biomedical Research Centres, Clinical Networks and experimental medical facilities are being built.

Isis Innovation
Isis Innovation Limited is wholly owned by the University of Oxford. Isis Innovation has three main business activities:

Isis helps Oxford University researchers to commercialise intellectual property arising from their research: patenting, licensing, spin-out companies.

Isis manages Oxford University Consulting which helps Oxford University researchers to identify and manage consulting opportunities and helps clients access experts from Oxford's world-class, interdisciplinary research base.

Isis Enterprise provides consulting expertise and advice in technology transfer and innovation management to clients across the public and private sectors around the world.

Isis was established by Oxford University in 1988 as its wholly owned technology transfer company. Isis has developed substantially over the years in a number of phases, as the technology transfer activity has grown, and with the formation of Oxford University Consulting and Isis Enterprise.

Isis manages the University’s intellectual property portfolio, working with University researchers on identifying, protecting and marketing technologies through licensing, spin-out company formation, consulting and material sales. Isis funds patent applications and legal costs, negotiates exploitation and spin-out company agreements, and identifies and manages consultancy opportunities. Isis works on projects from all areas of the University’s research activities: life sciences, physical sciences, social sciences and humanities. Isis provides access to Oxford’s expertise and provides researchers with advice on commercialisation.


Rufus Scientific Ltd - "Finding the opportunity"
Founded by experienced scientific and commercial entrepreneurs, Rufus Scientific provides a future-orientated understanding of what science and technology has achieved, where it can go, and how to take the first, critical steps along the road to get there. We have a track record of success at looking beyond fashions in science, technology and business, identifying the real value of innovation, in science or in its commercialization. We provide clients with the strategy, analysis and implementation to link great ideas to technical or commercial success in the life sciences. Rufus is proud to work with The Round Table, a collaborative group of independent advisors and executives in the life sciences, and with Consilient Ltd., a Cambridge (UK) based technical and marketing consultancy.

Rufus provides:

Identification of the real opportunity in leading-edge science and technology, for scientific, medical or commercial development
'Blue sky' research, in literature- and software based science and industry analysis, to test the 'next big thing'
Cartography of the route to market for new, science-based commercial projects
Business planning for the seed-stage and A-series start-up
Interim management to make it happen.

Venue and Directions:

Milton Park Innovation Centre
99 Milton Park
Abingdon
Oxfordshire
OX14 4RY
You can find a location map here. There will plenty of parking in front and behind the building. The nearest train station is Didcot Parkway, which is less than 10 minutes taxi ride from the Innovation Centre. There is also a shuttle bus and timetables can be found through this link.



How to register for the 16 March BioTuesday

Contact Rachael Tidbury and submit the delegate name, job title, corporate email address by phone 01865 594 640 or email info@obn.org.uk to reserve your place at this event, or register online at www.obn.org.uk

Cost of Attending
Delegates will fit into one of the following price catergories:
(a) £ Free - Delegates from OBN Full Member companies, OBN Sponsors, also bench scientists, Academics/Post-docs/PhD, and MBA Students.
(b) OBN Associate Member companies get one free place and pay £25.00 + VAT for further delegates
(c) Select the Standard fee if none of the above applies: £50+ VAT per person (eg. non-member)

You can find out more about joining OBN to receive the above benefits via our website: http://www.obn.org.uk

Payment: Payment is required in advance by invoice or Credit Card

Cancellation policy: In the event that you cancel your reservation one week prior to the event, full refund is available, less 25% Admin fee. Cancellation later than 1 week, no refund is available. Substitutions can be made up to 24 hours before the event.

Venue and Directions:
This meeting will take place at The Innovation Centre, 99 Milton Park, OX14 4RY. There is plenty of parking in front and behind the building. The nearest train station is Didcot Parkway, which is less than 10 minutes taxi ride from the Innovation Centre. There is also a shuttle bus between Didcot and Milton Park and timetables can be found through this link:

http://www.mepc.com/miltonpark/Travel/ShuttleBus.aspx

Milton Park Innovation Centre
99 Milton Park
Abingdon
Oxfordshire
OX14 4RY